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Abstract. We investigated the role of the integrins 
c~vB3 and c~v/~5 in mediating  vitronectin  adhesion  of 
three phenotypically  distinct cell types.  M21  human 
melanoma  cells and  H2981  lung carcinoma  cells use 
both otv-containing  integrins  in adhering  to vitronectin 
while UCLA-P3 lung carcinoma  cells adhere  exclu- 
sively with otv/~5. Specifically, monoclonal  antibodies 
directed to functional  epitopes on both receptors  were 
required  to block adhesion  of M21  or H2981  cells 
while adhesion  of UCLA-P3 cells to vitronectin  could 
be blocked with a  monoclonal  antibody to t~v/~5. Al- 
though both receptors are involved in M21  and H2981 
cell adhesion to vitronectin,  only tav/33 can be detected 
in focal contacts,  colocalizing with  vinculin,  talin,  and 
the ends of actin filaments,  while otv/~5 shows a dis- 
tinct,  nonfocal contact,  distribution on the cell surface. 
These results provide the first evidence that two homol- 
ogous integrins  that  recognize the same ligand distrib- 
ute differentially on the cell surface. 
I 
NTEGRINS are a family of heterodimeric proteins respon- 
sible for a wide variety of cellular adhesive functions 
involving  both  cell-cell  and  cell-matrix  interactions. 
The term integrin was derived from the ability of these pro- 
teins to link the extracellular environment with the cytoskel- 
eton  (Hynes,  1987).  Numerous  reports  have documented 
that cells attach and spread on ligands such as vitronectin, 
fibronectin, or collagen, and organize their respective integ- 
rin receptors into focal contacts that form at the end of actin 
filaments (Chen et al.,  1985; Damsky et al., 1985; Burridge 
et al., 1988; Singer et al., 1988; Dejana et al.,  1988; Carter 
et al.,  1990). These focal contacts contain not only the ap- 
propriate integrin but also cytoplasmic proteins such as vin- 
culin,  talin,  and ct-actinin  (Geiger,  1979;  Horwitz et al., 
1986; Tapley et al.,  1989; Nuckolls et al.,  1990; Otey et al., 
1990), which are thought to mediate the interaction between 
the integrin/ligand  structure on the outside of the cell with 
the actin-contalning microfilaments on the inside of the cell. 
The functional diversity of integrins is dictated by the par- 
ticular od~ subunit composition.  However, it is now clear 
that several integrins with distinct subunit composition rec- 
ognize the same ligand. For example, or2, o~3, and or6 when 
coupled to the ~1 subunit have demonstrated laminin recog- 
nition capability (Elices and Hemler, 1989; Languino et al., 
1989; Gehlsen et al., 1989; Sonnenberg et al., 1988). Varia- 
tion of the integrin ot subunit can also give rise to multiple 
receptors for collagen (Wayner and Carter,  1987; Elices and 
Hemler,  1989), fibronectin (Pytela et al.,  1985; Wayner et 
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al.,  1989), and fibrinogen (Cheresh et al.,  1989a, b; Smith 
et al.,  1990a,  b). 
Recently, it became evident that the c~v subunit was capa- 
ble of associating with multiple integrin/3 subunits (Cheresh 
et al.,  1989a; Freed et al.,  1989; Smith et al.,  1990b; Kris- 
sansen et al., 1990; Vogel et al., 1990; Bodary and McLean, 
1990). At present there are at least three distinct 13 subunits 
that associate with otv, namely,/31, 133, and/35. Some of these 
receptors have been shown to bind vitronectin in an Arg-Gly- 
Asp-dependent manner (Cberesh et al.,  1989a; Bodary and 
McLean,  1990).  However, txv/33 is capable of recognizing 
multiple Arg-Gly-Asp-containing ligands (Cheresh and Spiro, 
1987, Smith et al., 1990a; Charo et al., 1990) whereas otv/35 
(Cheresh et al., 1989a: Smith et al., 1990a) and txv/31 (Vogel 
et al.,  1990; Bodary and McLean,  1990) are clearly more 
restricted  in their adhesive functions. 
At present it is not clear what,  if any, biological signifi- 
cance can be attributed to the presence of different integrins 
with similar or identical ligand specificities. It is conceivable 
that distinct  integrins  that recognize the same ligand  may 
convey differential signals to the cell. Alternatively, one re- 
ceptor could be used for adhesion while a second receptor 
may potentiate cell migration. 
In this report, we investigated the role of the two vitronec- 
tin receptors, t~v/33 and av/35, in mediating cellular adhesion 
to vitronectin.  Our results demonstrate that while both re- 
ceptors are involved in the adhesion of a given cell to vitro- 
nectin,  postligand binding  events cause these receptors to 
differentially distribute on the cell surface. Once cells attach 
and spread on a vitronectin substrate, o~v/33  exclusively asso- 
ciates with focal contacts and therefore colocalizes with vin- 
culin and the ends of actin filaments, but ~v/35 on the same 
©  The Rockefeller University  Press, 0021-9525/91/05/919/11  $2.00 
The Journal of  Cell Biology, Volume 113, Number 4, May 1991 919-929  919 cell does not. This is the first evidence that two integrins on 
a given cell recognize the same ligand yet differentially seg- 
regate on the cell surface. These results clearly demonstrate 
that distinct integrins bound to the same ligand can promote 
differential posfligand binding events. 
Materials and Methods 
Cells and Cell Culture 
UCLA-P3 human lung carcinoma cells and M21 human melanoma cells 
were obtained from Dr. Donald Morton (Department of Surgery,  University 
of California, Los Angeles). A549 human lung carcinoma cells were ob- 
tained from the ATCC. H2981  human lung carcinoma cells were obtained 
from Dr. Diane Horn (Oncogen, Seattle, WA). Cells were grown in RPMI- 
1640 containing 10% fetal bovine serum and were free of mycoplasma dur- 
ing the course of these studies. 
Antibodies 
mAbs P5H9 and P3G2 (IgG1) directed to the integrin receptor c~v/~5 were 
produced as described by Wayner and Carter (1987) and Wayner et ai. (1988, 
1989).  Spleens from RBF/DnJ mice immunized with A549 lung carcinoma 
cells were removed and fused with NS-1/FOX-NY myeloma cells. Hybrid- 
omas producing antibody directed to carcinoma cell vitronectin receptors 
were screened by the specific inhibition of UCLA-P3 adhesion to vitronec- 
tin-coated surfaces and cloned by limiting dilution on thymocyte feeder lay- 
ers. The resulting monoclonal antibodies, P3G2 (ave5), PSH9 (av/35), and 
P3G8 (av) were used throughout the present studies. 
Other anti-integrin mAbs used included: LM609 (c~v/33), LMI42 (c~v), 
LM534  (/31 nonfunctional), P4C10  (El  functional), have been described 
(Cheresh and Harper, 1987; Cheresh, 1987; Carter et ai., 1990).  mAB AP3 
(Newman et al., 1985) to the integrin ~3 subunit was a generous gift from 
Dr. Peter Newman (Blood Center of Southeastern Wisconsin, Milwaukee, 
WI). Monoclonal anti-vitronectin, 8E6 (Hayman et al., 1983),  was a gen- 
erous gift from Dr.  Deane Mosher (University of Wisconsin, Madison, 
WI). Polyclonai anti-vitronectin was prepared by immunizing rabbits with 
purified human vitronectin. This reagent did not cross-react with any known 
adhesive ligand by immunofluorescence  or Western blotting. A rabbit poly- 
clonal antibody raised against a 20 residue peptide (CTHVDFTFNKFN- 
KSYNGTVD) derived from the COOH terminus of/~5 (Ramaswamy and 
Hemler, 1990) was a gift from Dr. Martin Hemler (Dana Farber, Boston, 
MA). mAb to the cytoskeletal protein vinculin was obtained from Sigma 
Chemical Co. (St. Louis, MO). Rabbit anti-talin was generously provided 
by Dr. Keith Burridge (University of North Carolina, Chapel Hill, NC). All 
antibodies were purified on protein A-Sepharose. 
Adhesive Ligands 
Human plasma fibronectin was prepared as described (Wayner and Carter, 
1987). Collagen type I was obtained from Collaborative Research (New Bed- 
ford, MA). Vitronectin was prepared as described (Yatohgo et al., 1988). 
Cell Adhesion Assay and Inhibition with 
Monoclonal Antibodies 
The cell adhesion assays were performed as previously described (Wayner 
and Carter, 1987; Wayner et al., 1988;  Carter et al., 1990) except that the 
following buffer was  used  for  the  adhesion  experiments:  RPMI  1640 
buffered  with  Hepes  (Gibco  Laboratories,  Grand  Island,  NY)  sup- 
plemented with 1%  BSA and  1 mM CaCI2,  1 mM MgC12, and  100/~M 
MnCI2.  Briefly,  virgin styrene 48-well plates (Costar,  Cambridge, MA) 
were coated with adhesive ligands (200/~l per well containing 5  ttg/ml 
ligand) and were blocked with PBS supplemented  with 5 % BSA. Melanoma 
and carcinoma cells in logarithmic growth were suspended by a  10-min 
treatment with versene, washed, resuspended in adhesion buffer and labeled 
with Na251CrO4 (50 t~Ci/ml for 30 rain). The chromium-labeled cells were 
allowed to adhere to the protein-coated surfaces for 15-30 rain at 37°C in 
the presence or absence of purified mAbs or ascites fluid to specific adhe- 
sion receptors diluted 1:200. At the end of the incubation, the nonadherent 
cells were removed and the adherent ceils were dissolved in SDS/NaOH and 
bound 51Cr epm were quantitated in a gamma counter. 
Fluorescence Analysis of  Receptor Expression and 
Localization of  Receptors in Focal  Adhesions 
Adherent cells were suspended with versene (as above), washed, and al- 
lowed to adhere to glass coverslips coated with 10 ~g/ml fibronectin, colla- 
gen type I, or vitronectin in the absence of serum for 30 mill at 37°C. After 
adhesion, the nonadherent cells  were removed and the adherent cells  were 
fixed with 3 % paraformaldehyde in HBSS for 30 max. They were permeabi- 
lized with 0.5 % Triton X-100 for 1 rain, washed, and blocked with 5 % BSA 
in PBS. The permeabilized cells were stained with antibodies to specific 
receptors or adhesive ligands (60 rain at room temperature), washed, in- 
cubated with either FITC-conjngated goat anti-mouse (Tago, Inc., Burlin- 
game, CA) or rhodamine-conjngated goat anti-rabbit IgG (Tago, Inc.) (60 
min at room temperature), and washed again. The coverslips were inverted 
onto glass slides for fluorescence microscopy as described (Wayner et al., 
1989;  Carter et ai.,  1990).  The actin-containing cytoskeleton was visual- 
ized by staining with FITC or rhndamine-conjngated  phalloidin diluted 1:50 
in  HBSS  containing  1%  BSA  (Sigma Chemical Co.).  Focal adhesions 
formed during the attachment of cells to vitronectin-coated surfaces were 
visualized by the exclusion ofa ligand specific antibody from the close con- 
tacts (Burridge et ai., 1988; Carter et al., 1990) and by vinculin colocaliza- 
tion (Geiger,  1979;  Burridge et al.,  1988). 
lmmunoprecipitation Analysis 
Cells were either surface labeled with 125I or metabolically labeled with 
[35S]cysteine and [35S]methionine  as previously described (Cheresh et al., 
1989a).  Radiolabeled cells were lysed with LCL (10 mM Tris,  150 mM 
NaCI, 1 mM CaC12, 0.02%  NAN3, pH 8.5) containing 2% Renex 30 deter- 
gent. The lysates were then subjected to immunopreeipitation as previously 
described (Cheresh et ai., 1989a). Immunoprecipitated proteins were ana- 
lyzed by SDS-PAGE under nonreducing conditions on 6% polyacrylamide 
gels. Radiolabeled proteins were visualized by autoradiography as previ- 
ously described (Cheresh,  1987). 
Results 
Monoclonal Antibody PSH9 Blocks Adhesion of 
UCLA-P3 to Vitronectin 
UCLA-P3  lung carcinoma cells express the vitronectin re- 
ceptor ,vfl5, originally designated as o~v/3x (Cheresh et al., 
1989a). mAbs were selected for their ability to block the at- 
tachment of these cells to vitronectin. As shown in Fig.  1, 
mAbs P5H9 and P3G2 (not shown) were selected based on 
their ability to inhibit the adhesion of UCLA-P3 cells to vi- 
tronectin while not affecting cell attachment to collagen, or 
fibronectin, mAb LM142 or P3G8 (not shown) directed to 
the o~v subunit of this receptor (Cheresh et al., 1989a) or mAb 
LM609 directed to the o~vfl3 complex (Chemsh and Spiro, 
1987) failed to inhibit UCLA-P3  cell attachment to any of 
the adhesive ligands (Fig.  1). In addition, mAb P4C10,  di- 
rected to a functional epitope on the integrin/31 subunit, in- 
hibited attachment of UCLA-P3 cells to collagen but failed 
to affect cell attachment to vitronectin or fibronectin. These 
results suggest that mAbs P5H9 and P3G2 recognize the pri- 
mary vitronectin receptor on UCLA-P3  cells. 
In a second experiment, we tested various concentrations 
of purified mAb P5H9 for their ability to block UCLA-P3 
adhesion to vitronectin. As shown in Fig. 2, this mAb inhib- 
ited cell attachment to vitronectin in a dose-dependent man- 
ner with half-maximal inhibition at '~0.5 t~g/rnl and complete 
inhibition was obtained at 10 t~g/ml. In contrast, mAb LM609 
directed to the vitronectin receptor avfl3 (Cheresh and Spiro, 
1987) failed to inhibit UCLA-P3 cell attachment at a concen- 
tration of 100/zg/ml. These results demonstrate that the mAb 
P5H9 recognizes the sole vitronectin receptor on UCLA-P3 
lung carcinoma cells. 
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Figure 1. UCLA-P3 cell adhesion to vitronectin, fibronectin,  and 
collagen: effect of mAb P5H9. UCLA-P3 cells  were radiolabeled 
with 5tCr and allowed to attach to microtiter wells coated with vi- 
tronectin, fibronectin,  or collagen in the presence of various mAbs 
(ascites fluid diluted  1:200) as described in Materials and Methods. 
After adhesion, nonadherent cells  were washed away and the re- 
maining cells were harvested and the cpm were determined in a 
gamma counter.  Data are expressed as percent of control adhesion, 
i.e.,  ceils incubated  in the absence of antibody.  In control wells, 
>50% of the cells added were attached. The mAbs used are as fol- 
lows: LM142 (c~v), LM609 (c~v/53), P5H9 (~xvB5), and P4C10 (B1). 
Each bar represents  the mean of triplicates  the standard error of 
which is routinely <10%.  ([]) VN; (1) FN; (1~) COL. 
mAb PSH9 Immunoprecipitates the Vitronectin 
Receptor avBS from UCLA-P3 and H2981 Lung 
Carcinoma Cells 
To characterize  the  molecule  on the  surface  of UCLA-P3 
carcinoma ceils recognized by mAb P5H9, ceils were surface 
120 
? 
100 
"~  so 
_g  so 
40 
:  ~o/O--"-°~O~o 
\ 
o  • 
t3 
~o~  •  . 
2O 
0  ::::',  :  :  ~::::~  :  :  :::::.,'-'-T  ~., 
0.1  1.0  10  100 
M~b  (ug/ml) 
Figure 2. The effect of varying concentrations of mAb P5H9 on the 
attachment of UCLA-P3 cells to vitronectin. UCLA-P3 cells were 
allowed to adhere to wells coated with vitronectin as in Fig.  1 in 
the presence of varying concentrations of  mAb P5H9 (solid circles) 
or mAb LM609-(open circles). Data are expressed  as the percent 
of control adhesion (i.e.,  cells incubated in the absence of anti- 
body). In control wells,  '~50 % of the cells of the cell population 
was adherent.  Each point represents  the mean level of adhesion in 
duplicate  wells. 
labeled  with  t25I, lysed in detergent,  and the  lysates  were 
subjected to immunoprecipitation.  As shown in Fig. 3 (left, 
lane C), mAb P5H9 immunoprecipitates a heterodimer con- 
sisting of an cx chain (160 kD) and a B chain (95 kD) under 
nonreducing conditions. This identical pattern was obtained 
with rnAb LM142 directed to the otv subunit (Fig. 3, lane A). 
In contrast, mAb LM609, directed to the otv/33 complex or 
mAb AP3, directed to the ~3 subunit,  failed to immunopre- 
cipitate any proteins from these cells (Fig. 3 le~, lanes B and 
D, respectively) consistent with previous results demonstrat- 
ing that UCLA-P3 cells lack o~vfl3 (Cheresh et al.,  1989a). 
To examine the expression of these receptors on another 
lung carcinoma cell,  H2981 cells were surface labeled and 
subjected to immunoprecipitation as above. As shown in Fig. 
Figure  3.  Molecular  profile  of  integrins 
c~vB3 and c~v/35 on UCLA-P3 and H2981 
cells.  UCLA-P3 cells (left) or H2981 cells 
(right) were surface-labeled  with  t25I,  ex- 
tracted  in detergent,  and the lysates  were 
subjected to immunoprecipit atiun with var- 
ious mAbs as described in Materials  and 
Methods. Samples were resolved by SDS- 
PAGE on 6% gels under nonreducing con- 
ditions and radiolabeled bands were visu- 
alized  by autoradiography as described in 
Materials  and  Methods.  Molecular  mass 
markers  are  indicated  to the  left  of each 
panel, mAbs used include LM142, directed 
to ctv (lane A); LM609, directed to txv~3 
(lane B); P5H9, directed to otvB5 (lane C) 
and AP3, directed to B3 (lane D). The mi- 
gration of ,w and/53 on these gels  is de- 
picted by arrows. 
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ognizes  the  integrin  av#5. 
UCLA-P3 cells were surface 
labeled, extracted with deter- 
gent, the lysate of which was 
subjected to immunoprecipi- 
tation as described in Fig. 3. 
However, before immunopre- 
cipitation,  lysates  were  pre- 
cleared three times with mAb 
LM609  (anti-avB3,  lanes 
A-D),  mAb  P5H9  (putative 
anti-otv/~5, lane E), mAb AP3 
(anti-/~3,  lane  F)  or  rnAb 
LM142 (anti-c~v, lane  G) as 
previously described (Cheresh 
et al.,  1989). Immunoprecip- 
itation of these precleared ly- 
sates was as follows: lane A, 
mAb  142  (anti-t~v); lane  B, 
mAb  LM609  (anti-c~v/~3); 
lanes C, F, and G, mAb P5H9 
(putative anti-otvfl5);  and lanes 
D and E, polyclonal anti-/35. 
Samples  were  analyzed  by 
SDS-PAGE  on 7.  5 (left) or 6 % 
(right) gels run under nonre- 
ducing conditions and radio- 
labeled proteins were visual- 
ized  by  autoradiography  as 
described in Fig. 2. 
3 C (right), mAb P5H9 immunoprecipitates a heterodimer 
identical to that observed from UCLA-P3 cells.  However, 
H2981 cells also express the integrin ctv/33 (Fig. 3 right, ar- 
rows) since mAbs LM609 (t~v/33 complex) and AP3 (/33) im- 
munoprecipitate both o~v and/33  from these cells (Fig.  3, 
lanes B and D, respectively). Therefore, mAb LM142 directed 
to the ,v subunit immunoprecipitates oe¢ together with/33 
(arrow) as well as the/3 subunit identified by mAb P5H9. 
To establish the identity of the heterodimer immunopre- 
cipitated with mAb P5H9, UCLA-P3 cell lysates were first 
subjected to  immunodepletion with  subunit  specific anti- 
integrin antibodies. This was followed by a second round of 
immunoprecipitation. AS shown in Fig. 4 (left), the radiola- 
beled lysate was depleted with mAb P5H9 or LM609, and 
then subjected to immunoprecipitation with mAb LM142, 
LM609, P5H9, or a/35-specific antibody (Ramaswamy and 
Hemler, 1990). Immunodepletion with mAb P5H9 (Fig. 4, 
lane E) completely depleted the/35 immunoreactive mate- 
rial,  whereas depletion with mAb LM609, directed to the 
~v/33 complex, did not (Fig. 4, lane D). AS expected, deple- 
tion with mAb P5H9 eliminated immunoreactivity with it- 
self  and with mAb LM142 but failed to deplete immunoreac- 
tivity with a/31-specific mAb (data not shown). Moreover, 
cross-depletion studies  using  rnAb  LM609  and  P5H9 on 
H2981 cell lysates, show absolutely no cross-reactivity be- 
tween these antibodies  (data not shown).  Taken together, 
these results indicate that the/3 subunit immunoprecipitated 
by mAb P5H9 is/35. 
To identify the ct subunit associated with/35 on these cells, 
lysates  were  first depleted with  mAb  AP3  (/33) or  mAb 
LM142 (c~v) and then subjected to immunoprecipitation with 
mAb P5H9. As shown in Fig. 4 (right), depletion with mAb 
LM142 specifically precleared the lysate of P5H9 reactivity 
whereas depletion with rnAb AP3  failed to do so.  These 
results indicate that the receptor recognized by mAb P5H9 
is the integrin c~v/35. This is consistent with our previous 
results where we demonstrated that mAb LM142 immuno- 
precipitated otv/3x (otv/35) from UCLA-P3 cells (Cheresh et 
al.,  1989a). That mAb P5H9 completely blocks UCLA-P3 
cell adhesion to vitronectin (Figs.  1  and 2)  suggests  that 
otv/35 is  the  sole vitronectin receptor expressed on these 
cells. 
In an attempt to characterize the relative abundance of 
vitronectin receptors av/35 and otv/33 on various cell types, 
lung carcinoma cell lines UCLA-P3 or H2981 or M21 hu- 
man melanoma cells were metabolically labeled and sub- 
jected to immunoprecipitation with mAb P5H9 directed to 
o0¢/35 or mAb LM609 directed to otv/33. As shown in Fig. 
5, mAb P5H9 immunoprecipitates a heterodimer from all 
three cell lines. In contrast, mAb LM609 directed to uv/~3 
immunoprecipitates a corresponding heterodimer from M21 
and H2981 cells yet fails to identify any protein in UCLA-P3 
cells.  Therefore these  cell  lines  represent  three  distinct 
phenotypes since M21 cells express mostly otv/33 and mini- 
mal levels of o~v/35, H2981 cells express similar levels of  both 
integrins while UCLA-P3 cells express otv/35 exclusively. 
Integrins t~v~5 and ~v~3 Are Both Involved in 
Adhesion of  M21 Melanoma and H2981 Carcinoma 
Cells to lqtronectin 
To determine whether otv/35 and otv/33 are both involved in 
cell adhesion to vitronectin M21 melanoma and 1-I2981 car- 
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cally labeled M21, H2981, and UCLA-P3 cells.  M21, H2981, or 
UCLA-P3 cells were metabolically labeled under steady-state con- 
ditions (18 h) with [35S]cysteine or [35S]methionine, lysed in deter- 
gent, and the lysates were subjected to immunoprecipitation  with 
mAb LM609 (uv/33, lane A) or mAb P5H9 (ix,  v/35, lane B) as de- 
scribed in Materials and Methods.  Samples were analyzed on 6% 
polyacrylamide  gels under nonreducing conditions and visualized 
by autoradiography as described in Fig. 2. Arrow refers to the bio- 
synthetic  precursor to c~v as previously  described  (Cheresh  and 
Harper,  1987; Cheresh  and Spiro,  1987). 
cinoma cells were allowed to attach to vitronectin in either 
the  presence  or  absence  of mAb  P5H9  and  LM609.  As 
shown in  Fig.  6,  neither  mAb alone (0.1-25  #g/ml) com- 
pletely blocks M21  or H2981  cell adhesion to vitronectin. 
It is apparent that mAb LM609  significantly reduced the 
adhesion of M21  cells while mAb P5H9  significantly re- 
duced the adhesion of H2981 cells. These results are consis- 
tent with the relative levels of etv/~3 and otv/35 expressed by 
these cells (Fig. 5). However, when these cells were allowed 
to react with a mixture of mAbs P5H9 and LM609 virtually 
all M21 cell adhesion to vitronectin was abolished (Fig. 7). 
The combined effects of both of these mAbs reduced 1-12981 
cell adhesion by 80% (Fig. 7). As a control, mAb W6/32 di- 
rected to HLA class I antigens present on these ceils failed 
to inhibit cell adhesion alone or when combined with either 
vitronectin receptor mAb (Fig. 7). In addition, mAbs P5H9 
or LM609 either separately or together had negligible effects 
on  the adhesion of  these cells  to fibronectin, collagen or laminin 
(data not shown). These results indicate that M21 and H2981 
cells use both oc,,/~3 and otv/~5 in adhesion to vitronectin. 
Integrins av/~3 and avB5 Exhibit a Distinct 
Distribution on the Surface of  M21 or 1-12981 Cells 
Attached to Vitronectin 
To determine the distribution of ave3 and c~v~5 on cells at- 
tached to vitronectin, immunofluorescence experiments were 
performed. M21, H2981, or UCLA-P3 cells were allowed to 
attach and spread on coverslips coated with vitronectin or 
various other ligands. As shown in Fig. 8, once M21 or H2981 
cells  attach  to  vitronectin  a  focal distribution  is  detected 
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Figure 6.  The effects of mAb P5H9  (ctv/~5) and  mAb LM609 
(av/$3) on H2981 and M21 cell adhesion to vitronectin.  M21 cells 
(top) or H2981 ceils (bottom) were radiolabeled with 5tCr, and al- 
lowed to attach to microtiter  wells coated with vitronectin  in the 
presence of varying concentrations of mAb P5H9 (solid circles) or 
mAb LM609 (open circles) as described in Materials and Methods. 
After adhesion,  nonadherent  cells were washed away and the re- 
maining cells were harvested  and the cpm were determined  in a 
gamma counter. Data are expressed as percent of control adhesion, 
i.e., cells incubated in the absence of antibody. In control wells, 
>50 % of  the cells added were attached. Each point represents mean 
of duplicate  samples. 
upon  staining  with  mAb AP3  directed  to  the/~3  subunit 
(Fig. 8, B and D). This staining pattern completely codistrib- 
utes with focal contacts as detected by these same cells stained 
with anti-vitronectin (Fig. 8 A). In this case, anti-vitronectin 
is  specifically excluded  from the  regions  of focal contact 
(Fig. 8, A, C, and E, arrows) and these regions codistribute 
with the staining pattern of/33 on M21 cells or H2981 cells 
(Fig.  8,  B  and D,  respectively, arrows). In contrast,  when 
H2981 cells are stained with anti-/35  (Fig. 8 F), a punctate 
distribution is observed over the entire ventral surface (Fig. 
8 F) which shows little or minimal colocaiization with focal 
contacts as depicted by anti-vitronectin exclusion (Fig. 8 E). 
A composite staining pattern of ~3 and/~5 is observed (Fig. 
8 H) when H2981 are reacted with mAb LM142 directed to 
the o~v subunit on these cells. Thus, it can be clearly seen 
that the immunolocaiization of the tx,  v subunit on these cells 
reveals both focal contact staining  (identified in Fig.  8  G, 
arrows)  as  well as the punctate  nonfocal contact  staining 
pattern. 
When M21 (Fig. 9, A and B) or H2981 cells (Fig. 9, E and 
F) are attached to vitronectin and cells are stained with both 
anti-/33  (Fig. 9, A and E) and anti-/~5 (Fig. 9, B and F) com- 
pletely distinct patterns are observed. Thus,/~3 is localized 
in a focal contact distribution (Fig. 9, arrows) while/~5 on 
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Figure 7. Integrins txv/35 and ~xv~3 are involved in M21 and H2981 
cell adhesion to vitronectin. Radiolabeled M21 cells (top) or H2981 
cells (bottom) were allowed to adhere to wells coated with vitronec- 
tin as described in Materials and Methods. Cell adhesion was per- 
formed either  in the absence  of antibody  (A) or in the presence 
25 #g/ml of the  following: mAb W6/32 (B; anti-HLA,  class I); 
rnAb LM 609, (C; anti-c~v/33); mAb P5H9, (D; anti-otv/35); mAb 
W6/32  +  mAb LM609,  (E); mAb W6/32 +  mAb P5H9 (F); or 
mAb LM609 +  mAb P5H9 (G). Data are expressed as the cells 
attached (cpm) to the wells, which in the absence of antibody treat- 
ment,  represents  approximately  50%  of the cells added to each 
well. Each bar represents the mean +  SD of triplicates. 
the same cell is not. As expected, when M21 cells are stained 
with a mAb directed to vinculin (Fig. 9, C) the focal contacts 
are detected.  This staining pattern shows no colocalization 
with these same cells stained with the anti-/35 antibody (Fig. 
9 D). As shown in Fig. 9, G and H, H2981 cells stained with 
anti-vinculin  show  the  expected focal contact distribution 
(arrows).  When these cells are stained with antibody to talin 
(Fig.  9  I) there is significant colocalization with vinculin 
(Fig. 9 H) but not/35 (Fig. 9, D  and F).  Thus, when cells 
are attached to vitronectin integrin av/33 is found in focal 
contacts colocalizing with vinculin and talin while integrin 
otv/35 does not. As a control, we examined the/33 distribution 
on H2981 and M21 cells attached to collagen. In this case, 
the cells did not organize B3 into focal contacts, but as ex- 
pected mAb LM534, directed to a nonfunctional epitope on 
/31, located this subunit in focal contacts on collagen (data 
not shown). These results are consistent with cell adhesion 
experiments in which rnAb P4C10, directed to a functional 
epitope on the/31 subunit, blocked collagen adhesion of all 
three  cell  lines  (data  not  shown).  Taken  together,  these 
results demonstrate that when cells are attached to vitronec- 
tin, t~v/33 and otv/35 demonstrate distinct distributions on the, 
cell surface even though both receptors are clearly involved 
in the attachment to this ligand. 
UCLA-P3  cells readily attach  to vitronectin but fail to 
spread and form focal contacts. As shown in Fig.  10 A, the 
/35 distribution on these cells shows a similar punctate stain- 
ing pattern as observed on M21  cells (Fig.  8) and H2981 
cells (Figs. 8 and 9). mAb LM!42, directed to txv or a poly- 
clonal antibody directed to c~v/33 that react with both recep- 
tors (Cheresh et al., 1989a) on UCLA-P3 cells demonstrate 
this identical staining pattern confirming the/35 staining pat- 
tern on these cells (data not shown). This lack of focal con- 
tact distribution is correlated with the inability of UCLA-P3 
ceils to organize actin during their adhesion to vitronectin 
(Fig.  10 B). In contrast,  M21  cells (Fig.  10 D), or H2981 
(Fig.  10 F) attached to vitronectin demonstrate well orga- 
nized  actin  filaments  as  depicted  on  cells  stained  with 
rhodamine-phalloidin.  As expected the 133  distribution  on 
M21 cells localizes at the ends of actin filaments (Fig.  10 C, 
arrows) whereas 135 on M21 cells (not shown) or H2981 cells 
does not (Fig. 10 E). It is of interest to note that on vitronec- 
tin-attached H2981 cells the actin filaments appear to orga- 
nize  around  the circumference of the  ventral cell  surface 
(Fig.  10 F) whereas on M21 cells the actin filaments appear 
to span the diameter of the cell (Fig.  10 D). 
The distinct localization of/33 and/35 on M21 and H2981 
cells attached to vitronectin (as shown above)were based on 
experiments in which cells were allowed to attach and spread 
on vitronectin for 30 min.  However, when M21  or H2981 
cells were allowed to attach and spread for 120 min we were 
still  unable to observe focal contact distribution  of otv/35 
(data not shown). These results indicate that integrin otv/35, 
involved in cell attachment to vitronectin, is incapable of as- 
sociating with the actin-cytoskeleton and therefore does not 
localize in focal contacts. 
Discussion 
In this report we investigated the mechanism of vitronectin 
adhesion of three phenotypically distinct cell types: (a) M21 
melanoma cells which express primarily otvB3 and a smaller 
amount of ~xvB5; (b) H2981 carcinoma cells which express 
similar levels of o~v/35 and cxvB3; and (c) UCLA-P3 carci- 
noma cells which exclusively express oev/35 (originally de- 
fined as integrin otv/3x [Cheresh et al.,  1989a; Smith et al., 
1990a]).  The M21  and H2981 cells use weB3 and avB5 to 
adhere and spread on vitronectin whereas  UCLA-P3 cells 
adhere,  but fail to spread on this substrate. 
Although otv/33 and <xvB5 are required for optimal adhe- 
sion of M21  and H2981  cells, these receptors distribute to 
Figure 8.  Immunofluorescence detection of c~v/33 and c~v/35 on the surface of M21  and H2981 cells. M21 (A and B) of H2981 (C-H) 
cells were allowed to attach and spread on vitronectin-coated coverslips for 30-45 min at 37°C, after which cells were fixed, permeabilized, 
and reacted with primary antibodies to vitronectin,  either mAb 8E6 (A and C) or rabbit anti-vitronectin antibody (E and G). Localization 
of 133 (B and D) or/35 (F) on these cells was achieved using the primary antibodies mAb AP3 and rabbit anti-/35 peptide, respectively. 
The composite staining of both receptors  was identified by mAb LM142 directed to ~xv (H). These antigens were detected with Frl'C- 
conjugated anti-mouse or rhodamine-conjugated anti-rabbit IgG. Arrows indicate focal contact staining as defined by anti-vitronectin exclu- 
sion in A, C, E, and G. Representative fields were photographed  using a Zeiss microscope  fitted with epifluorescence. Bar,  10 #m. 
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after adhesion of M21 or H2981 cells, all detectable surface- 
associated c~v/33 is localized to focal contacts whereas o~v/35 
is not. Instead, otv/35 appears in a punctate distribution over 
much of the ventral cell surface. UCLA-P3 cells, which ex- 
clusively use otv/35 to attach to vitronectin, also show a simi- 
lar nonfocal distribution.  In fact, in none of the three cell 
lines examined did c~v/35 localize to the ends of actin fila- 
ments or associate with vinculin. These results suggest one 
of  two possibilities. Either the/35 subunit is unable to associ- 
ate with these cytoskeletal proteins or is unable to mobilize 
them into focal contacts. This is of interest since previous 
studies demonstrated that both integrins recognize vitronec- 
tin in an Arg-Gly-Asp-dependent manner (Cheresh et al., 
1989a).  These results  suggest that distinct localization of 
these two receptors is not a consequence of a major differ- 
ence in their ligand binding capability. 
Of the three cell lines we examined, M21  exhibited the 
greatest degree of spreading on vitronectin, while H2981 
cells had a moderate capacity to spread and UCLA-P3 cells 
failed to do so. Consistent with these morphological obser- 
vations,  immunoprecipitation  analysis  demonstrated  that 
M21 cells expressed a high ctv/33//35 ratio whereas H2981 
cells revealed a relatively low otv/33//35 ratio and UCLA-P3 
cells express only ~v/35. By comparison, M21 cells spread 
considerably less on collagen indicating that these cells are 
not simply more capable of spreading in general. However, 
it should be pointed out that like M21 cells, UCLA-P3 cells 
use a/31-containing integrin to attach to collagen (Fig.  1), 
yet UCLA-P3 cells were unable to significantly spread on 
collagen or vitronectin suggesting the failure of these cells 
to spread on vitronectin is not entirely due to their exclusive 
expression of otv/35 as a vitronectin receptor. Although cell 
spreading is a complex molecular event, it is conceivable that 
the failure of otv/35 to associate with the actin-cytoskeleton 
may render this receptor incapable of inducing cell spread- 
ing on a vitronectin substrate. Thus, in order to spread on 
vitronectin, cells may require surface expression of txv/33, 
which is capable of promoting the organization of the actin- 
cytoskeleton in order to spread. 
Our inability to localize otv/35 to focal contacts is some- 
what surprising in light of previous published reports which 
have demonstrated both/31 and/33 integrin association with 
focal contacts. When cells are attached to fibronectin, colla- 
gen, and laminin, integrins containing the 131 subunit have 
been localized to focal contacts (Singer et al., 1988; Wayner 
et al., 1989; Carter et al.,  1990), whereas on vitronectin/33 
was localized to focal contacts (Singer et al.,  1988). These 
results suggest that integrins direct the organization of cy- 
toskeletal components in response to specific and relevant 
ligands. This is biologically important since redistribution of 
integrins into focal contacts causes cells to change shape 
in  response to  cytoskeletal rearrangements.  These  shape 
changes may affect cellular signaling and the migratory or 
proliferative capacity of the cell. Thus, the relative expres- 
sion of av/35 and/or av/33 on a cell surface may have pro- 
found effects on the biological behavior of that cell in the 
presence of vitronectin. 
In this study, the immunolocalization of  otv/35 on vitronec- 
tin-attached cells was performed using a polyclonal antibody 
directed to a 20 residue synthetic peptide derived from the 
COOH terminus of 135 (Ramaswamy and Hemler, 1990). It 
is conceivable that such an antibody might be sterically in- 
hibited when the 135  subunit is associated with the actin- 
cytoskeleton. In such a case one would expect selective ex- 
clusion of staining at the sites of focal contact formation. 
However, this is not the case, rather, the staining with the/35 
antibody is punctate over most, if not all, of the ventral sur- 
face of all three cell lines. It is also unlikely that all epitopes 
represented by a polyclonal antibody directed to a peptide of 
20 residues would be sterically unable to recognize/35 in as- 
sociation with the actin-cytoskeleton, when a polyclonal an- 
tibody prepared to a cytoplasmic peptide from 131 does local- 
ize within focal contacts (Marcantonio and Hynes,  1988). 
Moreover, staining these cells with a polyclonal antibody to 
av/33 or a mAb to ocv, either of which will recognize both 
receptors (Cheresh et al., 1989a; Smith et al., 1990a), dem- 
onstrates the composite 133 and/35 staining pattern of M21 
and H2981 and the exclusive/35 staining pattern on UCLA- 
P3 cells. 
It is likely that the distinct distribution of t~v/33 and otv/35 
is attributable to a structural difference between the/3 sub- 
units since both receptors share a common o~ subunit. The 
primary amino acid sequence of/33 (Fitzgerald et al., 1987) 
and/35 (Ramaswamy and Hemler, 1990; Suzuki et al., 1990; 
McLean et al.,  1990) show 56% identity. However,/35 con- 
tains a cytoplasmic domain that is distinct from that of/33. 
In fact, the cytoplasmic domain of/35 is only 10-20% ho- 
mologous to/33 or the other integrin/3 subunits (Ramaswamy 
and Hemler, 1990). Moreover,/35 contains a 10 residue car- 
boxy-terminal extension not found on/33 or any of  the known 
integrin/3 subunits. Since the cytoplasmic tail of the integrin 
/31 subunit has been implicated in focal contact formation 
(Solowska et al., 1989; Hayashi et al. 1990) it is conceivable 
that the unique cytoplasmic portion of 135 prevents its associ- 
ation with the actin-cytoskeleton. Alternatively, txv/35 might 
preferentially associate with cytoplasmic proteins other than 
the actin-cytoskeleton such as intermediate filaments. In ei- 
ther event, this would likely result in the failure of this re- 
ceptor to localize in focal contacts even though it maintains 
contact with its ligand. A similar model has been proposed 
for the integrin ot6/34 (Suzuki and Naitoh, 1990; Tamura et 
al.,  1990). This integrin has an unusually long cytoplasmic 
tail not found on any other integrin/3 subunits and also fails 
to enter focal contacts probably due to its association with 
intermediate filaments (Quaranta, V., personal communica- 
tion). In epithelial tissues tx6/34 exclusively localizes to the 
basolateral surface whereas the 131 subunlt is uniformly ex- 
pressed on the entire cell surface (Carter et al.,  1990). 
The results presented in our study provide the first evi- 
Figure 9. c~v135  and c~v133  expressed on M21 and H2981 cells demonstrate distinct distributions. M21 (A-D) or H2981 (E-I) cells attached 
to vitronectin coated coverslips were stained as in Fig. 8, except the primary antibodies used were mAb AP3 directed to t33 (A and E), 
rabbit anti-135 (B, D, and F), mAb directed to vinculin (C, G, and H), or rabbit anti-talin (I). The secondary antibodies used were identical 
to those in Fig. 8. Arrows refer to focal contacts as detected by 133 localization (A and E) or vinculin localization (C, G, and H). Representa- 
tive fields were photographed using a Zeiss microscope fitted with epifluorescence. Bar, 10 #m. 
Wayner et  al. Imegrins uv~3 and cry:35  Show a Distinct  Distribution  927 Figure 10. Integrin c~v/33 colocalizes  with the ends of actin filaments whereas  otv/35 does not.  UCLA-P3 (A and B), M21 cells (C and 
D) or H2981 cells (E and F) were allowed to attach to vitronectin-coated coverslips for 30 min and were stained with anti-/35 (A and 
E) or the anti-/33 mAb AP3 (C) as described above. Actin was visualized with FI'IC (B and F) or rhodamine-conjugated  phalloidin (D). 
Photos of representative  fields were taken with a Zeiss microscope  fitted with epifluorescence.  Magnification is 1,000 (A and B) or 630 
(C-F). When M21 or H2981 cells were allowed to spread for longer period (1-2 h) increased actin filament organization was observed 
whereas UCLA-P3 cells remained unspread with minimal  actin organization. The 30-rain  time was chosen to correspond to the localization 
of ~3 and/35. Bar,  10/~m. 
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ligand differentially  segregate on the cell surface.  This dis- 
tinct distribution can be accounted for by differential associa- 
tion with  the  actin-cytoskeleton.  Therefore,  two  integrins 
that bind the same ligand can provide distinct cellular sig- 
nals. Future experiments are aimed at elucidating these sig- 
nals at the molecular level and determining their consequence 
in terms of cellular differentiation and proliferation. 
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